MK0767 in Type 2 Diabetes (0767-012)

Summary

This is a clinical trial in patients with Type 2 Diabetes to test the safety of MK0767. This study will also see how effective MK0767 is in lowering markers of glucose metabolism and improving the lipid profile and non-HDL cholesterol when compared with placebo and pioglitazone.

Timeline

Start

2001-10

Primary completion

2003-11

Completion

2003-11

Drugs

Indications